| Page 1621 | Kisaco Research
 

Chris Sharp

Chief Technology Officer
Digital Realty

Chris Sharp has over 20 years of experience in the technology industry, with an extensive background in developing technology strategies in global markets. He has a deep knowledge of the data center sector and is well positioned to expand technical innovation at Digital Realty.

Chris Sharp

Chief Technology Officer
Digital Realty

Chris Sharp

Chief Technology Officer
Digital Realty

Chris Sharp has over 20 years of experience in the technology industry, with an extensive background in developing technology strategies in global markets. He has a deep knowledge of the data center sector and is well positioned to expand technical innovation at Digital Realty. Most recently, he was responsible for cloud innovation at Equinix, where he led the development of innovative cloud services solutions and developed new capabilities enabling next-generation, high-performance exchange and interconnection solutions, facilitating broad commercial adoption of cloud computing on a global basis. Previously, Mr. Sharp held leadership positions at top network and colocation providers, including Qwest Communications, MCI/Verizon Business and Reliance Globalcom.

 

Qun Wang

Reviewer
FDA

Qun Wang

Reviewer
FDA

Qun Wang

Reviewer
FDA
 

Laurent Chesnel

VP, Research & Development
Artugen Therapeutics

Laurent Chesnel

VP, Research & Development
Artugen Therapeutics

Laurent Chesnel

VP, Research & Development
Artugen Therapeutics
 

Sarah Garant

Director, CMC Manufacturing
Seres Therapeutics

Sarah Garant

Director, CMC Manufacturing
Seres Therapeutics

Sarah Garant

Director, CMC Manufacturing
Seres Therapeutics
 

Greg Perry

CFO
Finch Therapeutics

Greg Perry

CFO
Finch Therapeutics

Greg Perry

CFO
Finch Therapeutics
 

Christopher Weidenmaier

Head of Research and Development Operations
Finch Therapeutics

Christopher Weidenmaier

Head of Research and Development Operations
Finch Therapeutics

Christopher Weidenmaier

Head of Research and Development Operations
Finch Therapeutics
 

Heidi Hau

Director, Technology Expansion
Rebiotix

Heidi Hau

Director, Technology Expansion
Rebiotix

Heidi Hau

Director, Technology Expansion
Rebiotix
 

Lisa Larkin

CEO & Founder
Ms Medicine

Lisa Larkin

CEO & Founder
Ms Medicine

Lisa Larkin

CEO & Founder
Ms Medicine